| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/03/2008 | US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 06/03/2008 | US7381725 Pyridazine derivatives as ligands for GABA receptors |
| 06/03/2008 | US7381723 Antiserotonine agents; stroke, brain disorders;trauma; Alzheimer's disease; neurodegenerative disease; schizophrenia; psychological disorders; anxiolytic agents; controlling stresses; eating disorders; sleep disorders; sexual disorders |
| 06/03/2008 | US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide |
| 06/03/2008 | US7381537 Use of inhibitors of glutaminyl cyclases for treatment and prevention of disease |
| 06/03/2008 | CA2435954C Preparation of non-crystalline atorvastatin calcium |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2283465C Pesticidal 1-aryl-3-iminopyrazoles |
| 05/29/2008 | WO2008063984A2 Allosteric modulators of the a1 adenosine receptor |
| 05/29/2008 | WO2008062907A1 Substance capable of inhibiting cytokinin signaling |
| 05/29/2008 | WO2008062878A1 Novel pyrazole derivative, harmful organism control agent, and use of the control agent |
| 05/29/2008 | WO2008062770A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 05/29/2008 | WO2008062739A1 Pyrazoles and use thereof as drugs |
| 05/29/2008 | WO2008062424A2 Substituted 4,5-dihydro-1h-pyrazole derivatives as cannabinoid modulators |
| 05/29/2008 | WO2008062276A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 05/29/2008 | WO2008062011A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/29/2008 | WO2008061740A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 05/29/2008 | WO2008045564A3 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | WO2007146072A3 Process for synthesizing piperazine-piperidine compounds |
| 05/29/2008 | WO2007072150A3 Piperidine derivatives |
| 05/29/2008 | US20080125464 Prucalopride n-oxide |
| 05/29/2008 | US20080125444 Acyclic oximyl hepatitis c protease inhibitors |
| 05/29/2008 | US20080125441 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 05/29/2008 | US20080125438 2-aminothiophene derivatives; {2-Amino-4-[(4-phenylpiperazin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic for chronic neuropathic pain, cardiac disarrhythmias, angina; neurological disease or injury, sleep disorder, epilepsy, antidepressants |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125422 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080124572 A carbazole skeleton to which a diarylamino group bonds via a bonding group as a hole transporting material or a hole injecting material has an enhanced efficiency of light emission and is highly practical; enhances yield in device, improves lifetime |
| 05/29/2008 | US20080124426 Ketomethionine ketals and derivatives thereof |
| 05/29/2008 | CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 05/29/2008 | CA2669275A1 Agent for inhibiting cytokinin signaling |
| 05/29/2008 | CA2669083A1 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 05/29/2008 | CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/28/2008 | EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 05/28/2008 | EP1924568A1 Quinazoline derivatives useful in cancer treatment |
| 05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924551A2 Organic compounds |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | CN101189229A Synthesis of avrainvillamide, stephacidin B, and analogues thereof |
| 05/28/2008 | CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
| 05/28/2008 | CN101186606A Ampelopsin derivative, synthesizing method thereof and application of the same in preparing antineoplastic medicine |
| 05/28/2008 | CN100390166C Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390156C Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390153C Intermediate for producing novel pyrazine derivatives |
| 05/27/2008 | US7378532 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378518 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378421 Chromenone derivatives |
| 05/27/2008 | US7378419 3-{[(5,5a,8a,9)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]amino}-1-methyl-1H-pyrrole-2,5-dione; anticarcinogenic agent; inhibiting catalytic activity of topoisomerase II by stabilization of cleavable complex; better soluble and tolerated |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378375 Substituted pyridine herbicides |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008059960A1 Method for producing quarter-pyridine derivative and intermediate of quarter-pyridine derivative |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059259A2 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core |
| 05/22/2008 | WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors |
| 05/22/2008 | WO2008059130A1 Thionucleosides and pharmaceutical applications |
| 05/22/2008 | WO2008058402A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | WO2008042282A3 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 05/22/2008 | WO2008029257A3 Improved method for preparing 1,3-disubstituted pyrrolidine compounds |
| 05/22/2008 | WO2008021926A3 Modulators of glucocorticoid receptor, and/or ap-1, and/or nf-kb activity and use thereof |
| 05/22/2008 | WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
| 05/22/2008 | US20080119526 Ep2 receptor agonists |
| 05/22/2008 | US20080119516 2-'4(Phenylamino)-Piperidin-1-Yl!-N-Phenyl-Acetamine Derivatives and Related Compounds as Neuropeptide Y5 (NPY5) Ligands for the Treatment of Obesity |
| 05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119485 Novel Benzofurans and Indols |
| 05/22/2008 | US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/22/2008 | US20080119477 N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | CA2669704A1 Sulfoximines as kinase inhibitors |
| 05/22/2008 | CA2669607A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668744A1 Compounds and methods for treating protein folding disorders |
| 05/22/2008 | CA2668596A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2668592A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | CA2667569A1 Thionucleosides and pharmaceutical applications |
| 05/22/2008 | CA2666903A1 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | CA2666685A1 Synthesis of selected stereoisomers of certain substituted alcohols |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |